Bluejay Diagnostics Inc. – Filings and Transcripts

NASDAQ: BJDX
Share price (9/9/26): $1.01
Market cap (9/9/26): $4.513 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

Prospectuses and Registrations Filter

Registration of securities for employees

Prospectus supplement

Shelf registration

Prospectus supplement

Shelf registration

Ownership Filter

Wurth Douglas Clark

News Filter

Bluejay Diagnostics and Lovell Government Services Announce Partnership to Expand Access to U.S. Federal Healthcare Markets

Reports Q2 2026 Results; Strengthened Balance Sheet Supports Advancement of Symphony™ IL-6 Toward Regulatory Submission and Commercialization

Announces Successful Completion of Enrollment in the SYMON-II Multicenter Clinical Validation Study

Change in Directors, Officers or Compensation, Shareholder Vote Results, Financial Statements or Exhibits

Announces Up to $23.6 Million Private Placement Priced At-The-Market Under NASDAQ Rules

Proxies Filter

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Other Filter

Notice of effectiveness

Notice of effectiveness

Correspondence with the SEC

Notice of effectiveness

Correspondence with the SEC